(Q35872956)

English

Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells

scientific article published in November 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

A de Cupis

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

D Noonan

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

P Pirani

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

A Ferrera

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

L Clerico

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

R E Favoni

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

language of work or name

0 references

publication date

1 November 1995

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

British Journal of Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

116

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

2391-2400

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

The unliganded estrogen receptor (ER) transduces growth factor signals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Antioestrogens in the management of hormone-dependent cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Regulation of human breast cancer by secreted growth factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Characterization of the estrogen receptor in two antiestrogen-resistant cell lines, LY2 and T47D.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Anti-steroidal and anti-growth factor activities of anti-estrogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Autocrine and paracrine growth regulation of breast cancer: clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Potential role of tamoxifen in prevention of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

A potent specific pure antiestrogen with clinical potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Identification of insulin-like growth factor binding proteins in breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Insulin-like growth factor binding proteins in human breast cancer cells: relationship to hIGFBP-2 and hIGFBP-3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Endocrine therapy for advanced breast cancer: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

27 July 2018

Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

24 September 2018

Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

24 September 2018

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1111/J.1476-5381.1995.TB15085.X

21 January 2018

Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909063

14 November 2018

The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel steroidal pure antiestrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factors in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Action of "pure" antiestrogens in inhibiting estrogen receptor action

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunoassay of somatomedin C/insulin-like growth factor I

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8581274

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1476-5381.1995.TB15085.X

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35872956&oldid=1522809230"